EUVIMEDEUVIMED entdecken
Crossref

Relationship between maternal mortality and ritodrine hydrochloride as a tocolytic agent in Japan

Masamitsu Nakamura iD, Akihiko Sekizawa, Junichi Hasegawa iD, Masahiko Nakata iD, Shinji Katsuragi iD, Hiroaki Tanaka iD, Takeshi Murakoshi, Naohiro Kanayama, Isamu Ishiwata, Tomoaki Ikeda, Maternal Death Exploratory Committee in Japan

Journal of Obstetrics and Gynaecology Research · 2024-07 · 50 (7) · 1111-1117

DOI: 10.1111/jog.15951 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, online erschienen am 16.04.2024. Verfasst von Masamitsu Nakamura und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Fujita Health University, Aichi, Japan. Hauptthemen laut MEDLINE: Ritodrine, Tocolytic Agents, Maternal Mortality. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

In Japan, unlike Western countries, tocolytic agents are administered in long‐term protocols to treat threatened preterm labor. Evaluating the side effects of this practice is crucial. We examined whether ritodrine hydrochloride had been administered in cases of maternal death, aiming to investigate any relationship between ritodrine administration and maternal death.

Methods

This retrospective cohort study used reports of maternal deaths from multiple institutions in Japan between 2010 and 2020. Data on the reported cases were retrospectively analyzed, and data on the route of administration, administered dose, and clinical findings, including causes of maternal death, were extracted. The amount of tocolytic agents was compared between maternal deaths with ritodrine administration and those without.

Results

A total of 390 maternal deaths were reported to the Maternal Death Exploratory Committee in Japan during the study period. Ritodrine hydrochloride was administered in 32 of these cases. The frequencies ( n ) and median doses (range) of oral or intravenous ritodrine hydrochloride were 34.4% (11) and 945 (5–2100) mg and 84.4% (27) and 4032 (50–18 680) mg, respectively. Frequencies of perinatal cardiomyopathy, cerebral hemorrhage, diabetic ketoacidosis, and pulmonary edema as causes of maternal death were significantly higher with ritodrine administration than without it.

Conclusions

Our results suggest a relationship between long‐term administration of ritodrine hydrochloride and an increased risk of maternal death due to perinatal cardiomyopathy, cerebral hemorrhage, diabetic ketoacidosis, and pulmonary edema. In cases where ritodrine should be administered to prevent preterm labor, careful management and monitoring of maternal symptoms are required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RitodrineTocolytic AgentsMaternal MortalityHumansFemalePregnancyJapanRetrospective StudiesAdultObstetric Labor, PrematurePulmonary Edema

Stichwörter der Autor:innen

high‐dose administrationmaternal mortalityperinatal mortalityritodrine hydrochloridetocolysis

Substanzen

RitodrineTocolytic Agents

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Fujita Health University, Aichi, Japan.
  • Department of Obstetrics and Gynecology, Showa University School of Medicine, Tokyo, Japan.
  • Department of Obstetrics and Gynecology, St. Marianna School of Medicine, Kanagawa, Japan.
  • Department of Obstetrics and Gynecology, Toho University School of Medicine, Tokyo, Japan.
  • Department of Obstetrics and Gynecology, Miyazaki University, Miyazaki, Japan.
  • Department of Obstetrics and Gynecology, Mie University, Mie, Japan.

ORCID-Profile: Masamitsu Nakamura, Junichi Hasegawa, Masahiko Nakata, Shinji Katsuragi, Hiroaki Tanaka

Zitieren

APA

Nakamura, M., Sekizawa, A., Hasegawa, J., Nakata, M., Katsuragi, S., Tanaka, H., Murakoshi, T., Kanayama, N., Ishiwata, I., Ikeda, T., & Maternal Death Exploratory Committee in Japan (2024). Relationship between maternal mortality and ritodrine hydrochloride as a tocolytic agent in Japan. Journal of Obstetrics and Gynaecology Research, 50(7), 1111-1117. https://doi.org/10.1111/jog.15951

Vancouver

Nakamura M, Sekizawa A, Hasegawa J, Nakata M, Katsuragi S, Tanaka H, et al. Relationship between maternal mortality and ritodrine hydrochloride as a tocolytic agent in Japan. Journal of Obstetrics and Gynaecology Research. 2024;50(7):1111-1117. doi:10.1111/jog.15951

BibTeX
@article{Nakamura2024,
  author = {Nakamura, Masamitsu and Sekizawa, Akihiko and Hasegawa, Junichi and Nakata, Masahiko and Katsuragi, Shinji and Tanaka, Hiroaki and Murakoshi, Takeshi and Kanayama, Naohiro and Ishiwata, Isamu and Ikeda, Tomoaki and Maternal Death Exploratory Committee in Japan, Maternal Death Exploratory Committee in Japan},
  title = {Relationship between maternal mortality and ritodrine hydrochloride as a tocolytic agent in Japan},
  journal = {Journal of Obstetrics and Gynaecology Research},
  year = {2024},
  volume = {50},
  number = {7},
  pages = {1111--1117},
  doi = {10.1111/jog.15951}
}
Kostenlos starten →